Larvol Delta - Kiromic-BioPharma-Reports-Favorable-Safety-Tolerability-and-Early-Efcacy-from-Third-Patient-in-Deltacel01-Clinical-Trial

Deltacel (KB-GDT-01) - Kiromic

https://www.businesswire.com/news/home/20241008657194/en/Kiromic-BioPharma-Reports-Favorable-Ongoing-Clinical-Results-From-Fourth-and-Sixth-Patients-Enrolled-in-Deltacel-01

Oct 8, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next